Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena news boosts Orexigen, Vivus shares
Seeking Alpha
Saturday, May 12, 2012 - 11:16am
tags:
Arena Pharmaceuticals, Orexigen, Vivus, lorcaserin, Contrave, Qnexa, obesity, weight loss
Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'
Seeking Alpha
Friday, May 11, 2012 - 12:36pm
tags:
Watson Pharmaceuticals, JNJ, Novartis, Pfizer
Mylan launches generic Lipitor in France, U.K.
Marketwatch
Friday, May 11, 2012 - 12:30pm
tags:
Mylan, generics, Lipitor, France, UK
Pfizer Set To Surge On 3 New Drug Candidates
Seeking Alpha
Friday, May 11, 2012 - 12:22pm
tags:
Pfizer, Abbott Laboratories, Amgen, AstraZeneca, Watson Pharmaceuticals, JNJ, Bristol-Myers Squibb
Buy One, Get One Free at Charles River Laboratories
Yahoo/Morningstar
Friday, May 11, 2012 - 11:28am
tags:
Charles River Laboratories, CROs
Analysis And Valuation: J&J, Pfizer, Merck
Seeking Alpha
Friday, May 11, 2012 - 11:26am
tags:
JNJ, Merck, Pfizer
Endocyte Reports First Quarter 2012 Financial Results and Operations Update
Yahoo
Friday, May 11, 2012 - 11:24am
tags:
Endocyte, earnings
These 2 Pharma Giants Explain Critical New Developments
Wall St. Cheat Sheet
Friday, May 11, 2012 - 11:23am
tags:
Pfizer, JNJ, generics, Lipitor, Thermacool
More drug companies to pay billions for fraud, join the "dishonor roll" after Abbott settlement
Forbes
Friday, May 11, 2012 - 11:21am
tags:
whistleblower lawsuits, Abbott Laboratories, Pfizer, GSK, Eli Lilly, JNJ
Amag Pharma falls after ending sale talks
Yahoo/AP
Friday, May 11, 2012 - 11:20am
tags:
Amag Pharmaceuticals, M&A
Gilead’s Pill Wins U.S. Panel Backing to Prevent HIV
Bloomberg
Friday, May 11, 2012 - 11:18am
tags:
Gilead, HIV, Truvada
MannKind Narrows Loss
Yahoo/Zacks
Thursday, May 10, 2012 - 12:15pm
tags:
earnings, MannKind
Johnson & Johnson Remains Too Big to Succeed
TheStreet.com
Thursday, May 10, 2012 - 11:33am
tags:
JNJ
Arena Pharma: FDA Panel Live Blog
TheStreet.com
Thursday, May 10, 2012 - 11:13am
tags:
FDA, Arena Pharmaceuticals, advisory panels, obesity, lorcaserin
Biotech startup Egalet lassos $14.3M B round, new CEO
Fierce Biotech
Thursday, May 10, 2012 - 11:09am
tags:
Egalet
Novartis to investigate alleged approval irregularities in India, Reuters says
The Fly on the Wall
Thursday, May 10, 2012 - 11:08am
tags:
Novartis, India
1 Biotech With 2 Binary Events in 2 Days
Motley Fool
Thursday, May 10, 2012 - 11:07am
tags:
Gilead, HIV, Truvada, Quad
Using lucrative strategy, Johnson & Johnson seeks fifth use of anticlotting drug
Yahoo/AP
Thursday, May 10, 2012 - 11:00am
tags:
Bayer, JNJ, Xarelto, bloodthinners
Court Rebuffs Labor Dept. On Sales Rep Overtime
Forbes
Thursday, May 10, 2012 - 10:59am
tags:
Department of Labor, drug reps, overtime lawsuits
Dealpolitik: Glaxo v Human Genome: When Vulnerabilities Are Strengths
WSJ Online
Thursday, May 10, 2012 - 10:58am
tags:
GSK, M&A, Human Genome Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.